Description

Boiron S.A., founded in Messimy, France, in 1932, is a pharmaceutical company dedicated to the production and global sale of homeopathic medicines. Its market presence spans France, the broader European continent, North America, and numerous international territories. The company's offerings range from non-proprietary and proprietary formulations to a variety of branded homeopathic treatments. Among its prominent branded homeopathic products are Oscillococcinum, targeting influenza symptoms like fever, chills, headaches, and body aches; Stodal and Stodaline, developed for cough relief; Arnigel, for the localized adjunctive treatment of benign trauma without open wounds; Camilia, designed to alleviate teething problems in babies; and Sédatif PC, prescribed for anxiety, emotional distress, and minor sleep disorders. Additional homeopathic solutions include Coryzalia, for cold symptoms and rhinitis; Homéoptic, to soothe eye discomfort and irritation in all age groups; and Homéovox, for vocal disturbances. Beyond its core homeopathic range, Boiron also provides a selection of other health and wellness products. These encompass dietary supplements; the Dermoplasmine series (stick, balm, and mousse) for addressing dry lips and skin; Mag' Nuit, a formulation to assist with falling asleep; Arnitrosium, for joint pain; Castor Equi Boiron ointment, for cracked skin treatment; and Storinyl, a syrup to manage colds. Furthermore, the company offers herbal medicines, such as Canephron, which promotes diuresis and improved urinary elimination, alongside moisturizing baby milk and medical devices, including a range of COVID-19 self-tests and rapid antigenic tests. Boiron's products reach consumers through a comprehensive distribution network comprising dedicated centers, pharmacies, pharmacy chains, wholesalers, grocery stores, drugstores, health food stores, and various online retail channels.